Founded in 1999, Dexcom, Inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1999
Size (employees)
1,900 (est)+57%
Website
dexcom.com
Dexcom was founded in 1999 and is headquartered in San Diego, US

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr

Dexcom Metrics

Dexcom Financial Metrics

Dexcom's revenue was reported to be $573.3 m in FY, 2016 which is a 43% increase from the previous period.

Revenue (FY, 2016)

$573.3 m

Revenue growth (FY, 2015 - FY, 2016), %

43%

Gross profit (FY, 2016)

$378.4 m

Gross profit margin (FY, 2016), %

66%

Net income (FY, 2016)

($65.6 m)

EBIT (FY, 2016)

($63.9 m)

Market capitalization (23-May-2017)

$5.8 b

Closing share price (23-May-2017)

$68.9

Cash (31-Dec-2016)

$94.5 m

EV

$5.7 b
Dexcom's current market capitalization is $5.8 b.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$160 m$259.2 m$402 m$573.3 m

Revenue growth, %

62%55%43%

Cost of goods sold

$59.9 m$82.9 m$123.6 m$194.9 m

Gross profit

$100.1 m$176.3 m$278.4 m$378.4 m

Gross profit Margin, %

63%68%69%66%

Operating expense total

$129 m$197.8 m$335.5 m$442.3 m

EBIT

($28.9 m)($21.5 m)($57.1 m)($63.9 m)

EBIT margin, %

(18%)(8%)(14%)(11%)

Interest expense

$900 k$800 k$400 k$700 k

Interest income

$400 k

Pre tax profit

($29.8 m)($22.3 m)($57.5 m)($64.9 m)

Income tax expense

$100 k$100 k$100 k$700 k

Net Income

($29.8 m)($22.4 m)($57.6 m)($65.6 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$43.2 m$71.8 m$86.1 m$94.5 m

Accounts Receivable

$26.1 m$42.4 m$74.1 m$101.7 m

Inventories

$9 m$16 m$35.2 m$45.4 m

Current Assets

$93.1 m$145.9 m$231.3 m$280 m

PP&E

$20.7 m$31.2 m$54.7 m$109.4 m

Goodwill

$3.2 m$3.2 m$3.7 m$11.3 m

Total Assets

$122.5 m$184.6 m$292 m$402.8 m

Total Debt

$6.8 m$4.6 m$2.3 m

Current Liabilities

$32.1 m$40.6 m$66.9 m$102.4 m

Additional Paid-in Capital

$559.5 m$638 m$776.8 m$905.7 m

Retained Earnings

($475.4 m)($497.8 m)($555.4 m)($621 m)

Total Equity

$84.1 m$140.2 m$221.2 m$283.8 m

Debt to Equity Ratio

0.1 x0 x0 x

Debt to Assets Ratio

0.1 x0 x0 x

Financial Leverage

1.5 x1.3 x1.3 x1.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($29.8 m)($22.4 m)($57.6 m)($65.6 m)

Depreciation and Amortization

$7 m$8.4 m$10.8 m$15 m

Accounts Receivable

($6.5 m)($16 m)($32 m)($27 m)

Inventories

($1.6 m)($7 m)($19 m)($9.8 m)

Cash From Operating Activities

$2.4 m$23.6 m$49 m$56.2 m

Purchases of PP&E

($7.9 m)($16.2 m)($33.3 m)($55.7 m)

Cash From Investing Activities

$20.9 m($16.8 m)($51.5 m)($55.9 m)

Long-term Borrowings

($200 k)($2.2 m)($2.3 m)($2.3 m)

Cash From Financing Activities

$11.8 m$21.8 m$16.8 m$8.1 m

Interest Paid

$500 k$400 k$300 k$100 k
Y, 2016

EV/EBIT

-89.9 x

EV/CFO

102.2 x

Financial Leverage

1.4 x

Dexcom Operating Metrics

FY, 2016

Patents (US)

334

Patents (foreign)

48

Patents Pending

417

Trademarks (US)

24

Trademarks Foreign

54

Trademarks Pending

38

Facilities

2

Dexcom Market Value History

Dexcom Revenue Breakdown

Dexcom Job Categories

Dexcom Median Salaries

Source: 23 public H-1B filings from Dexcom

Dexcom Online Presence

Dexcom News

Dexcom Company Life

You may also be interested in